Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 108190
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.108190
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.108190
Figure 1 Life cycle of hepatitis B virus replication and infection before and after entering hepatocytes.
A: Normal liver; B: Liver with chronic hepatitis B virus infection. cccDNA: Covalently closed circular DNA; HBV: Hepatitis B virus; HBcAg: Hepatitis B core antigen; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; PgRNA: Pregenomic RNA.
- Citation: Zhu W. Therapeutic and preventive treatment on outcomes of hepatitis B virus induced chronic liver disease with a cost-effectiveness analysis. World J Gastrointest Pharmacol Ther 2025; 16(3): 108190
- URL: https://www.wjgnet.com/2150-5349/full/v16/i3/108190.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i3.108190